Five Prime Therapeutics, Inc. (FPRX) Financial Statements (2024 and earlier)
Company Profile
| Business Address |
111 OYSTER POINT BOULEVARD SOUTH SAN FRANCISCO, CA 94080 |
| State of Incorp. | DE |
| Fiscal Year End | December 31 |
| Industry (SIC) | 2834 - Pharmaceutical Preparations (benchmarking) |
| More info | Complete Financial Analysis Financial Benchmarking |
Balance Sheet (Statement of Financial Position) ($ in thousands)
| 12/31/2020 | 12/31/2019 | 12/31/2018 | 12/31/2017 | 12/31/2016 | 12/31/2015 | 12/31/2014 | |||
|---|---|---|---|---|---|---|---|---|---|
| ASSETS | |||||||||
| Current Assets | |||||||||
| Cash, cash equivalents, and short-term investments | 156,380 | 270,138 | 292,690 | 421,748 | 517,466 | 149,054 | |||
| Cash and cash equivalents | 55,800 | 43,953 | 59,790 | 7,653 | 149,971 | 15,267 | |||
| Short-term investments | 100,580 | 226,185 | 232,900 | 414,095 | 367,495 | 133,787 | |||
| Receivables | 4,097 | 5,096 | 13,133 | 3,959 | 4,054 | 410 | |||
| Other undisclosed current assets | 6,243 | 13,334 | 5,367 | 14,418 | 6,761 | 1,794 | |||
| Total current assets: | 166,720 | 288,568 | 311,190 | 440,125 | 528,281 | 151,258 | |||
| Noncurrent Assets | |||||||||
| Operating lease, right-of-use asset | 30,934 | ✕ | ✕ | ✕ | ✕ | ✕ | |||
| Property, plant and equipment | 22,534 | 28,718 | 30,762 | 6,207 | 4,539 | 3,794 | |||
| Restricted cash and investments | 1,543 | 1,543 | |||||||
| Deferred costs | 1,900 | 1,700 | |||||||
| Other noncurrent assets | 2,411 | 2,705 | 552 | 406 | 394 | 579 | |||
| Other undisclosed noncurrent assets | 1,543 | 1,543 | 13,171 | (1,700) | |||||
| Total noncurrent assets: | 57,422 | 32,966 | 32,857 | 8,156 | 20,004 | 4,373 | |||
| TOTAL ASSETS: | 224,142 | 321,534 | 344,047 | 448,281 | 548,285 | 155,631 | |||
| LIABILITIES AND EQUITY | |||||||||
| Liabilities | |||||||||
| Current Liabilities | |||||||||
| Accounts payable and accrued liabilities | 17,648 | 24,703 | 36,912 | 23,726 | 61,091 | 7,245 | |||
| Taxes payable | 46,437 | ||||||||
| Employee-related liabilities | 6,805 | 7,383 | 7,156 | 7,957 | 6,878 | 4,618 | |||
| Accounts payable | 1,184 | 1,972 | 2,237 | 334 | 1,894 | 1,096 | |||
| Accrued liabilities | 9,659 | 15,348 | 27,519 | 15,435 | 5,882 | 1,531 | |||
| Deferred revenue | 1,296 | ✕ | ✕ | ✕ | ✕ | ✕ | |||
| Debt | 4,080 | ||||||||
| Deferred rent credit | 1,356 | ✕ | ✕ | ✕ | ✕ | ||||
| Deferred revenue and credits | ✕ | ✕ | ✕ | 14,069 | 15,015 | 18,277 | 12,570 | ||
| Contract with customer, liability | ✕ | ✕ | 1,428 | ✕ | ✕ | ✕ | ✕ | ||
| Other undisclosed current liabilities | |||||||||
| Total current liabilities: | 23,024 | 27,487 | 50,981 | 38,741 | 79,368 | 19,815 | |||
| Noncurrent Liabilities | |||||||||
| Long-term debt and lease obligation: | 45,532 | ||||||||
| Liabilities, other than long-term debt | 5,113 | 28,908 | 27,864 | 17,965 | 32,428 | 50,611 | |||
| Deferred revenue and credits | ✕ | ✕ | ✕ | 27,864 | 17,856 | 32,133 | 50,142 | ||
| Deferred revenue | 5,113 | ✕ | ✕ | ✕ | ✕ | ✕ | |||
| Contract with customer, liability | ✕ | ✕ | 10,465 | ✕ | ✕ | ✕ | ✕ | ||
| Deferred rent credit | 18,443 | ✕ | ✕ | ✕ | ✕ | ||||
| Other liabilities | 109 | 295 | 469 | ||||||
| Operating lease, liability | 45,532 | ✕ | ✕ | ✕ | ✕ | ✕ | |||
| Total noncurrent liabilities: | 50,645 | 28,908 | 27,864 | 17,965 | 32,428 | 50,611 | |||
| Total liabilities: | 73,669 | 56,395 | 78,845 | 56,706 | 111,796 | 70,426 | |||
| Equity | |||||||||
| Equity, attributable to parent | 150,473 | 265,139 | 265,202 | 391,575 | 433,206 | 85,205 | |||
| Common stock | 35 | 34 | 28 | 27 | 26 | 22 | |||
| Additional paid in capital | 582,243 | 559,892 | 421,257 | 396,635 | 372,605 | 274,180 | |||
| Accumulated other comprehensive income (loss) | 78 | (106) | (476) | (39) | (74) | 1 | |||
| Retained earnings (accumulated deficit) | (431,883) | (294,681) | (155,607) | (5,048) | 60,649 | (188,998) | |||
| Total equity: | 150,473 | 265,139 | 265,202 | 391,575 | 433,206 | 85,205 | |||
| Other undisclosed liabilities and equity | 3,283 | ||||||||
| TOTAL LIABILITIES AND EQUITY: | 224,142 | 321,534 | 344,047 | 448,281 | 548,285 | 155,631 | |||
Income Statement (P&L) ($ in thousands)
| 12/31/2020 | 12/31/2019 | 12/31/2018 | 12/31/2017 | 12/31/2016 | 12/31/2015 | 12/31/2014 | ||
|---|---|---|---|---|---|---|---|---|
| Revenues | 14,874 | 49,868 | 39,508 | 30,691 | 379,801 | |||
| Revenue, net | ✕ | ✕ | ✕ | 39,508 | 30,691 | 379,801 | ||
| Gross profit: | 14,874 | 49,868 | 39,508 | 30,691 | 379,801 | |||
| Operating expenses | (156,812) | (196,023) | (190,910) | (129,903) | (92,828) | (56,805) | ||
| Other undisclosed operating income | 19,231 | |||||||
| Operating income (loss): | (141,938) | (146,155) | (151,402) | (99,212) | 286,973 | (37,574) | ||
| Nonoperating income | 4,736 | 5,708 | 2,884 | 2,467 | 484 | 150 | ||
| Investment income, nonoperating | 4,736 | 5,708 | 2,978 | 2,467 | 487 | 210 | ||
| Other nonoperating income (expense) | (94) | (3) | (60) | |||||
| Income (loss) from continuing operations before income taxes: | (137,202) | (140,447) | (148,518) | (96,745) | 287,457 | (37,424) | ||
| Income tax expense (benefit) | (1,704) | 31,048 | (37,810) | |||||
| Income (loss) from continuing operations: | (137,202) | (140,447) | (150,222) | (65,697) | 249,647 | (37,424) | ||
| Income (loss) before gain (loss) on sale of properties: | (137,202) | (140,447) | (150,222) | (65,697) | 249,647 | (37,424) | ||
| Net income (loss) available to common stockholders, diluted: | (137,202) | (140,447) | (150,222) | (65,697) | 249,647 | (37,424) | ||
Comprehensive Income ($ in thousands)
| 12/31/2020 | 12/31/2019 | 12/31/2018 | 12/31/2017 | 12/31/2016 | 12/31/2015 | 12/31/2014 | ||
|---|---|---|---|---|---|---|---|---|
| Net income (loss): | (137,202) | (140,447) | (150,222) | (65,697) | 249,647 | (37,424) | ||
| Other comprehensive income (loss) | 184 | 370 | (437) | 35 | (75) | (2) | ||
| Comprehensive income (loss), net of tax, attributable to parent: | (137,018) | (140,077) | (150,659) | (65,662) | 249,572 | (37,426) | ||
Statements Sources
The financial statements are based on the Company's filings with the U.S. Securities and Exchange Commission (SEC) through the Electronic Data Gathering, Analysis, and Retrieval system (EDGAR). The information is derived from the 10-K and 10-Q reports submitted to the SEC in XBRL (eXtensible Business Reporting Language) format and presented according to the US GAAP Taxonomy. Please review the original filings for a more detailed information.